US Pharma MarketingNew PDUFA deal allots money to rehire FDA reviewers, trade groups say
PhRMA says FDA will get money it can spend only on hiring and keeping staff, to restore reviewer levels after the HHS layoffs. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The…
Top pharmaceutical trade groups say the FDA will have a dedicated pool of money to replenish its stable of reviewers as part of the new Prescription Drug User Fee Act (PDUFA) agreement, after HHS layoffs ...
Source: Endpoints News